subject: CHEBI:8382


subject: CHEBI:8382

subject_name: Prednisone

object_name: Recurrent Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage

tested_intervention: unsure


subject: CHEBI:8382

object_name: Recurrent Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:132212657

subject_name: Revumenib

object_name: Refractory Acute Leukemia of Ambiguous Lineage


subject: PUBCHEM.COMPOUND:132212657

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: Refractory Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged


subject: PUBCHEM.COMPOUND:132212657

object_name: Recurrent Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged


subject: PUBCHEM.COMPOUND:132212657

object_name: Recurrent Acute Leukemia of Ambiguous Lineage


subject: PUBCHEM.COMPOUND:132212657

object_name: Refractory Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage


subject: PUBCHEM.COMPOUND:132212657

object_name: Refractory Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:132212657

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:132212657


subject: PUBCHEM.COMPOUND:132212657

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:132212657


subject: PUBCHEM.COMPOUND:169490859

subject_name: Revumenib citrate


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C5446872

subject_name: Ponsegromab

object_name: colorectal cancer

tested_intervention: yes


subject: UMLS:C5446872

object_name: colorectal carcinoma


subject: UMLS:C5446872

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5446872

object_name: pancreatic neoplasm


subject: UMLS:C5446872

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5446872

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB18580

object_name: Pick Complex


subject: DRUGBANK:DB18580

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: DRUGBANK:DB18580

object_name: frontotemporal dementia


subject: DRUGBANK:DB18580

object_name: Pick disease


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: plasma cell leukemia


subject: UMLS:C2983777


subject: UNII:349552KRHK

subject_name: Simendan

object_name: heart valve disorder


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Hyponatremia


subject: PUBCHEM.COMPOUND:27991

object_name: Hyponatremia, CTCAE


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: UMLS:C0086135

subject_name: DDAVP


subject: UMLS:C0086135


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: achondroplasia


subject: UMLS:C0169964

subject_name: somatropin


subject: UNII:6897GXD6OE

object_name: cardiovascular disorder


subject: UNII:6897GXD6OE

object_name: atrial fibrillation


subject: UNII:6897GXD6OE

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:6897GXD6OE

object_name: Atrial Fibrillation, CTCAE


subject: UNII:6897GXD6OE

object_name: acute myocardial infarction


subject: UNII:6897GXD6OE

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: Poor Performance Status


subject: UNII:308PA1L567

subject_name: Endoxifen Hydrochloride

object_name: HER2 positive


subject: UMLS:C2987366


subject: UMLS:C5445010

object_name: pancreatic neoplasm


subject: UMLS:C5445010

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5445010

object_name: malignant pancreatic neoplasm


subject: UMLS:C5445010

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5445010

object_name: Pancreatic cancer non-resectable


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Post-Operative Pain


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Tumor Mass


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C3257082

subject_name: Fish extract

object_name: nephrolithiasis


subject: UMLS:C3257082

object_name: urolithiasis


subject: PR:000014829

subject_name: SH3 and PX domain-containing protein 2A


subject: PR:000014829


subject: CHEBI:40279

subject_name: Allopurinol


subject: CHEBI:40279


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: cardiac allograft vasculopathy


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:135005

subject_name: Milnacipran

object_name: osteoarthritis, knee


subject: CHEBI:135005

object_name: chronic pain (diagnosis)


subject: CHEBI:135005

object_name: Chronic pain


subject: CHEBI:31347

subject_name: camostat mesylate

object_name: protein-losing enteropathy


subject: UMLS:C0108225

subject_name: Camostat mesylate


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: amyloidosis


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Heart failure with normal ejection fraction


subject: UMLS:C4526674

subject_name: Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6

object_name: pancreatic neoplasm


subject: UMLS:C4526674

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4526674

object_name: malignant pancreatic neoplasm


subject: UMLS:C4526674

object_name: Neck Carcinoma


subject: UMLS:C4526674

object_name: head and neck neoplasm


subject: UMLS:C4526674

object_name: head and neck cancer


subject: UMLS:C4526674

object_name: liver cancer


subject: UMLS:C4526674

object_name: liver neoplasm


subject: UMLS:C4526674

object_name: Adult Liver Carcinoma


subject: UMLS:C4526674

object_name: liver carcinoma


subject: UMLS:C4526674

object_name: colon carcinoma


subject: UMLS:C4526674

object_name: colorectal cancer


subject: UMLS:C4526674

object_name: colon cancer


subject: UMLS:C4526674

object_name: lung cancer


subject: UMLS:C4526674

object_name: lung neoplasm


subject: UMLS:C4526674

object_name: lung carcinoma


subject: UMLS:C4526674

object_name: squamous cell carcinoma


subject: UMLS:C4526674

object_name: bile duct carcinoma


subject: UMLS:C4526674

object_name: bile duct cancer


subject: UMLS:C4526674

object_name: cholangiocarcinoma


subject: UMLS:C4526674

object_name: sacrum chordoma


subject: UMLS:C4526674

object_name: adult lymphoma


subject: UMLS:C4526674

object_name: lymphoma


subject: UMLS:C4526674

object_name: pediatric lymphoma


subject: UMLS:C4526674

object_name: malignant soft tissue neoplasm


subject: UMLS:C4301616

subject_name: fluoroestradiol (18F)

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C5439626

subject_name: Fluoroestradiol f 18, diagnostic, 1 millicurie


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: Soft tissue rheumatism


subject: CHEBI:184693

object_name: temporomandibular joint disorder


subject: UMLS:C4329327

subject_name: Anti-Glypican 3/CD3 Bispecific Antibody ERY974

object_name: Solid Neoplasm


subject: UMLS:C2981819

object_name: Oncogenic osteomalacia


subject: CHEBI:63451

subject_name: Infigratinib


subject: CHEBI:10112

subject_name: Zileuton

object_name: interstitial lung disease 1


subject: CHEBI:10112

object_name: interstitial lung disease 2


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Diaper Rash


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:45409

subject_name: Ritonavir

object_name: cancer


subject: CHEBI:45409

object_name: neoplasm


subject: PR:000014028

subject_name: GTP-binding protein Rit1


subject: PR:000014028


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: complicated coal workers' pneumoconiosis


subject: CHEBI:70714

subject_name: Teflaro

object_name: Bacteremia caused by Staphylococcus aureus


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: CHEBI:90943

subject_name: Osimertinib

object_name: small cell lung carcinoma


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: primary ovarian failure


subject: CHEBI:6715

object_name: premature menopause


subject: UNII:X85G7936GV

subject_name: Abciximab

object_name: diabetes mellitus


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: pulmonary eosinophilia


subject: CHEBI:182913

object_name: Asthmatic pulmonary eosinophilia


subject: CHEBI:182913

object_name: asthma


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:8356


subject: UMLS:C5853391

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5853391

object_name: Childhood Solid Neoplasm


subject: UMLS:C5853391

object_name: Adult Solid Neoplasm


subject: UMLS:C5853391

object_name: Solid Neoplasm


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Large prostate


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Snake Bites


subject: CHEBI:28918

object_name: Snake bite (morphologic abnormality)


subject: CHEBI:194548

subject_name: Racepinephrine


subject: CHEBI:194548


subject: CHEBI:8461

subject_name: Promethazine


subject: CHEBI:8461


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: PUBCHEM.COMPOUND:168445332

object_name: Alzheimer disease


subject: UMLS:C4305844


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: radicular; neuropathic, lumbar, lumbosacral


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:31498

subject_name: Simethicone

object_name: female infertility


subject: CHEBI:31498

object_name: Sterility, Postpartum


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: Diabetes


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: type 1 diabetes mellitus 1


subject: CHEMBL.COMPOUND:CHEMBL4297797

object_name: type 1 diabetes mellitus


subject: UMLS:C5853357


subject: UMLS:C5853357


subject: UMLS:C5853357


subject: UMLS:C5853357


subject: UMLS:C5853357


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Acute myocardial infarction: rehabilitation phase


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Mesothelioma


subject: CHEBI:49960

object_name: mesothelial neoplasm


subject: CHEBI:49960

object_name: malignant mesothelioma


subject: UMLS:C2000001

object_name: hypertension


subject: UMLS:C2000001

object_name: Hypertension, CTCAE


subject: CHEBI:35480

subject_name: analgesic

object_name: Post-traumatic pain


subject: UMLS:C4762300

subject_name: Antihemophilic factor (recombinant), glycopegylated-exei

object_name: hemophilia A


subject: CHEBI:190692

subject_name: substance P(3+)

object_name: migraine


subject: CHEBI:190692

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:80308

subject_name: substance P


subject: CHEBI:80308


subject: UNII:675VGV5J1D

subject_name: SUBSTANCE P


subject: UNII:675VGV5J1D


subject: UMLS:C0038585

subject_name: Substance P


subject: UMLS:C0038585


subject: UMLS:C5204560

subject_name: Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:33387

subject_name: neptunium atom


subject: CHEBI:53793

subject_name: (4-hydroxy-3-nitrophenyl)acetyl group


subject: CHEBI:73425

subject_name: Asn-Pro


subject: CHEBI:50803

subject_name: nanoparticle


subject: MESH:C058314

subject_name: nucleoprotein, Measles virus


subject: UNII:6D5766Q4OP

subject_name: Olipudase alfa

object_name: Niemann-Pick disease type A


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:4F4X42SYQ6

object_name: Metastatic Cutaneous Melanoma


subject: UNII:4F4X42SYQ6

object_name: stage IIIB melanoma


subject: UNII:4F4X42SYQ6

object_name: stage IIIA melanoma


subject: UNII:4F4X42SYQ6

object_name: stage IIIC melanoma


subject: UNII:4F4X42SYQ6

object_name: Unresectable Melanoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Locally Advanced Thyroid Gland Medullary Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Thyroid Gland Medullary Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Sporadic Thyroid Gland Medullary Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Thyroid Gland Medullary Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Thyroid Gland Medullary Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: multiple endocrine neoplasia type 2A


subject: PUBCHEM.COMPOUND:131769963

object_name: multiple endocrine neoplasia type 2B


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: coronary artery disorder


subject: CHEBI:194186

object_name: coronary atherosclerosis


subject: CHEBI:194186

object_name: Coronary microvascular dysfunction


subject: CHEBI:194186

object_name: Angina pectoris


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Treatment related acute myeloid leukaemia


subject: UNII:M89N0Q7EQR

object_name: Recurrent Acute Myeloid Leukemia


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: HLA-A*0201 Positive Cells Present


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Pancreatic carcinoma non-resectable


subject: UNII:3A58010674

object_name: Unresectable Biliary Tract Carcinoma


subject: UNII:3A58010674

object_name: Unresectable Bile Duct Carcinoma


subject: UMLS:C5666916

subject_name: Nebratamig

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Confusion, CTCAE 3.0


subject: CHEBI:4466

object_name: Bewilderment


subject: CHEBI:4466

object_name: Confusion, CTCAE 5.0


subject: CHEBI:4466

object_name: Confusion


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:40303

subject_name: Lovastatin

object_name: Osteopenia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: abdominal abscess


subject: CHEBI:63611

object_name: Secondary Peritonitis


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:25681

object_name: familial hypercholesterolemia


subject: UNII:64J9J55263

subject_name: Tezosentan

object_name: Acute Heart Failure Related to COVID-19


subject: UNII:64J9J55263

object_name: Acute heart failure


subject: CHEBI:15379

subject_name: Oxygen

object_name: Pneumonia caused by Human coronavirus


subject: CHEBI:45409

subject_name: Ritonavir


subject: UMLS:C0013162

subject_name: Drug Combinations

object_name: cancer


subject: UMLS:C0013162

object_name: neoplasm


subject: UNII:98BSN6N516

subject_name: Rogaratinib


subject: UMLS:C5198671


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: obstructive sleep apnea syndrome


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: chordoma


subject: UMLS:C2347328

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2347328

object_name: clear cell renal carcinoma


subject: UMLS:C2347328

object_name: renal cell adenocarcinoma


subject: UMLS:C2347328

object_name: renal cell carcinoma


subject: UMLS:C2347328

object_name: squamous cell carcinoma


subject: UMLS:C2347328

object_name: epithelioid sarcoma


subject: UMLS:C2347328

object_name: adult epithelioid sarcoma


subject: UMLS:C2347328

object_name: childhood epithelioid sarcoma


subject: UMLS:C2347328

object_name: liver carcinoma


subject: UMLS:C2347328

object_name: melanoma


subject: UMLS:C2347328

object_name: fibromatosis


subject: UMLS:C2347328

object_name: desmoid tumor


subject: UMLS:C2347328

object_name: Desmoid tumor


subject: UMLS:C2347328

object_name: PEComa


subject: UMLS:C2347328

object_name: colorectal cancer


subject: UMLS:C2347328

object_name: colorectal carcinoma


subject: UMLS:C2347328

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C2347328

object_name: urothelial carcinoma


subject: UMLS:C2347328

object_name: transitional cell carcinoma


subject: UMLS:C2347328

object_name: Hodgkin Disease


subject: UMLS:C2347328

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C2347328

object_name: Ewing sarcoma


subject: UMLS:C2347328

object_name: Activating MTOR Gene Mutation


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:5959

subject_name: Irbesartan

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:5959

object_name: obesity


subject: CHEBI:5959

object_name: Obesity, CTCAE


subject: CHEBI:202393

object_name: neoplasm


subject: UMLS:C3896785

subject_name: Egfr t790m inhibitor pf-06747775

object_name: non-small cell lung carcinoma


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:465284

object_name: myoclonic dystonia 11


subject: CHEBI:465284


subject: CHEBI:465284

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:465284

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: viral pneumonia


subject: CHEBI:177636

subject_name: Bevenopran

object_name: kidney failure


subject: CHEBI:6904

subject_name: Metoprolol

object_name: psoriasis


subject: CHEBI:15365

subject_name: Aspirin

object_name: sickle cell disease


subject: UMLS:C0445115

subject_name: Normal saline

object_name: osteoarthritis


subject: CHEBI:27732

subject_name: Caffeine

object_name: Arrhythmia


subject: CHEBI:135901

subject_name: lanreotide

object_name: Pancreatic fistula


subject: CHEBI:135901

object_name: Pancreatic Fistula, CTCAE


subject: CHEBI:135901

object_name: Pancreatic leak


subject: CHEBI:135901

object_name: fistula; pancreaticoduodenal


subject: CHEBI:135901

object_name: pancreatectomy; hyperglycemia


subject: CHEBI:15365

object_name: Adult Solid Neoplasm


subject: CHEBI:2677

subject_name: Augmentin

object_name: tic disorder


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:OS7097575K

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C3827108


subject: UMLS:C3827108


subject: DRUGBANK:DB17571

subject_name: Uzansertib


subject: DRUGBANK:DB17571


subject: UMLS:C4086723


subject: UMLS:C4086723


subject: CHEBI:31781

subject_name: Lopinavir

object_name: Mitochondrial toxicity


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:63613

subject_name: Nevirapine


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: hepatitis C


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: Weight loss


subject: UMLS:C0002521

object_name: Weight Loss, CTCAE


subject: UMLS:C1517800

subject_name: Imo (pharmacologic substance)

object_name: Decompensated cirrhosis of liver


subject: PUBCHEM.COMPOUND:9884233

subject_name: ALBUTEROL SULFATE

object_name: Severe Bronchopulmonary Dysplasia


subject: CHEBI:2549

subject_name: Albuterol


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022

object_name: EXCESS LMW-DNA


subject: UMLS:C4733690

object_name: rheumatoid arthritis


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Control of hip fracture risk


subject: UMLS:C2984025

object_name: hip fracture


subject: RXCUI:1721613

subject_name: cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet

object_name: HIV infection


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Did not receive therapy or drug for


subject: CHEBI:4026

object_name: MYC Gene Rearrangement


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:54556623

subject_name: Zabofloxacin

object_name: Community-Acquired Pneumonia


subject: CHEBI:23044

subject_name: carotenoid

object_name: retinopathy of prematurity


subject: CHEBI:23044

object_name: exudative vitreoretinopathy 1


subject: CHEBI:23044

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:35147

subject_name: alpha-Carotene


subject: CHEBI:35147


subject: CHEBI:35147


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: hepatitis A


subject: UNII:G8RGG88B68

object_name: hepatitis


subject: UNII:G8RGG88B68

object_name: fibrosis


subject: CHEBI:94463


subject: UMLS:C1170576

subject_name: Rebetol


subject: UMLS:C1170576


subject: UMLS:C1170576


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C5706546

subject_name: Anti-Claudin18.2 Antibody-drug Conjugate IBI343

object_name: Stomach cancer


subject: UMLS:C5706546

object_name: gastric cancer


subject: UNII:PUY08529FK

subject_name: Eleclazine

object_name: hypertrophic cardiomyopathy


subject: UNII:PUY08529FK

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:91899

object_name: Allergic Fungal Sinusitis


subject: CHEBI:3207

subject_name: Budesonide


subject: PUBCHEM.COMPOUND:21873177

subject_name: Chondroitin Sulphate

object_name: osteoarthritis, knee


subject: CHEBI:145592


subject: CHEBI:61025

subject_name: Chondroitin


subject: CHEBI:16137


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: cardiotoxicity


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:85364156

object_name: Anorexia


subject: UMLS:C3886758


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Refractory Leukemia


subject: UNII:D07V79Q44T


subject: UMLS:C1566164


subject: UNII:6N79I7X5II

subject_name: VALEMETOSTAT TOSYLATE

object_name: B-cell neoplasm


subject: UMLS:C5238968

subject_name: Valemetostat Tosylate


subject: CHEBI:39585

subject_name: Carbidopa

object_name: thrombocytopenia 1


subject: CHEBI:66964

subject_name: Dronabinol

object_name: red-green color blindness


subject: CHEBI:66964

object_name: Deuteranomaly


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:3219

subject_name: Bupropion

object_name: stimulant use


subject: CHEBI:3219

object_name: Recurrent disease


subject: CHEBI:3219

object_name: Global Relapse in Viscera


subject: CHEBI:3219

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:3219

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:3219

object_name: Global Relapse


subject: CHEBI:3219

object_name: Global Relapse in Skin


subject: CHEBI:3219

object_name: Global Relapse in Blood


subject: RXCUI:1551468

subject_name: 12 HR bupropion hydrochloride 90 MG / naltrexone hydrochloride 8 MG Extended Release Oral Tablet


subject: RXCUI:1551468

object_name: attention deficit hyperactivity disorder, inattentive type


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: RXCUI:1551468


subject: CHEBI:60481

object_name: HIV Coinfection


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000022493


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: CHEBI:63453

object_name: Gastroesophageal junction cancer


subject: CHEBI:63453

object_name: gastric cancer


subject: UMLS:C0012802

subject_name: Thiazide Diuretics

object_name: essential hypertension


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: refractory malignant neoplasm


subject: CHEBI:91400

subject_name: Afatinib


subject: UNII:B1HEG7V21S

object_name: pulmonary tuberculosis


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UMLS:C4287690

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: UMLS:C4287690

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: head and neck squamous cell carcinoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: CHEBI:49140

object_name: plasma cell myeloma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: UMLS:C5238480


subject: CHEBI:132082

subject_name: Entinostat

object_name: leukemia


subject: CHEBI:132082

object_name: childhood leukemia


subject: CHEBI:132082

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:132082

object_name: acute myeloid leukemia


subject: CHEBI:36928

subject_name: carbon-13 atom

object_name: type 2 diabetes mellitus


subject: CHEBI:36928

object_name: Diabetes


subject: CHEBI:36928

object_name: diabetes mellitus


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0062248

subject_name: Hemoglobin B


subject: UMLS:C0062248


subject: UMLS:C0062248


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: corneal endothelial dystrophy


subject: UMLS:C1707756

subject_name: Alcon


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: UMLS:C3826995

subject_name: Iodine I 124 Phospholipid Ether Analogue CLR1404

object_name: glioblastoma


subject: UMLS:C3826995

object_name: Childhood Glioblastoma


subject: UMLS:C3826995

object_name: adult glioblastoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Progressive cGVHD


subject: UNII:PQX0D8J21J

object_name: Progressive Disease


subject: UNII:PQX0D8J21J

object_name: Progressive Neoplastic Disease


subject: UNII:PQX0D8J21J

object_name: IMWG Progressive Disease


subject: UNII:PQX0D8J21J

object_name: irPD (Immune-Related Response Criteria)


subject: UNII:PQX0D8J21J

object_name: Global Progressive Disease in Viscera


subject: UNII:PQX0D8J21J

object_name: RECIL PD


subject: UNII:PQX0D8J21J

object_name: Global Progressive Disease in Skin


subject: UNII:PQX0D8J21J

object_name: Global Progressive Disease


subject: UNII:PQX0D8J21J

object_name: Global Progressive Disease in Lymph Nodes


subject: UNII:PQX0D8J21J

object_name: Global Progressive Disease in Blood


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: UNII:8L7891MRB6

object_name: Unresectable Rectal Adenocarcinoma


subject: UNII:8L7891MRB6

object_name: Colorectal cancer recurrent


subject: UNII:8L7891MRB6

object_name: Unresectable Colon Adenocarcinoma


subject: UNII:8L7891MRB6

object_name: Progressive cGVHD


subject: UNII:8L7891MRB6

object_name: Progressive Disease


subject: UNII:8L7891MRB6

object_name: Progressive Neoplastic Disease


subject: UNII:8L7891MRB6

object_name: IMWG Progressive Disease


subject: UNII:8L7891MRB6

object_name: irPD (Immune-Related Response Criteria)


subject: UNII:8L7891MRB6

object_name: Global Progressive Disease in Viscera


subject: UNII:8L7891MRB6

object_name: RECIL PD


subject: UNII:8L7891MRB6

object_name: Global Progressive Disease in Skin


subject: UNII:8L7891MRB6

object_name: Global Progressive Disease


subject: UNII:8L7891MRB6

object_name: Global Progressive Disease in Lymph Nodes


subject: UNII:8L7891MRB6

object_name: Global Progressive Disease in Blood


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Postimplantation syndrome


subject: CHEBI:6888

object_name: Descending aortic dissection


subject: CHEBI:94463

object_name: Drug usage


subject: CHEBI:94463

object_name: Drug use history


subject: CHEBI:94463

object_name: Encounter due to drug use


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: CHEBI:85083


subject: CHEBI:82977

subject_name: Daclatasvir


subject: CHEBI:82977


subject: CHEBI:82977


subject: UMLS:C1337333

subject_name: SESTAMIBI

object_name: mucocutaneous lymph node syndrome


subject: UMLS:C5856912

subject_name: Copper 64 Cu-labeled Macrophage-targeted Nanoparticle

object_name: cancer


subject: UMLS:C5856912

object_name: neoplasm


subject: UMLS:C5856912

object_name: sarcoidosis


subject: UMLS:C5856912

object_name: Equine sarcoid of skin


subject: UMLS:C5856912

object_name: cardiovascular disorder


subject: UNII:N7T15V1FUY

subject_name: Setmelanotide

object_name: hypertriglyceridemia


subject: UNII:N7T15V1FUY

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C4552025

subject_name: Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine

object_name: melanoma


subject: CHEBI:71015

subject_name: perampanel hydrate

object_name: Bilateral tonic-clonic seizure with generalized onset


subject: PUBCHEM.COMPOUND:11627655

subject_name: Almorexant

object_name: insomnia


subject: PUBCHEM.COMPOUND:11627655

object_name: Insomnia, CTCAE 3.0


subject: PUBCHEM.COMPOUND:11627655

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:201431

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:201431

object_name: Chronic lymphoid leukemia in remission


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:9168


subject: CHEBI:3392

subject_name: Carbendazim

object_name: adult lymphoma


subject: CHEBI:3392

object_name: lymphoma


subject: CHEBI:3392

object_name: pediatric lymphoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: hemangioma


subject: UNII:12M44VTJ7B

subject_name: DALTEPARIN SODIUM

object_name: Thromboembolism


subject: UNII:12M44VTJ7B

object_name: Deep vein thrombosis of lower limb


subject: UNII:12M44VTJ7B

object_name: Deep venous thrombosis


subject: UMLS:C0498888

subject_name: INJECTION, DALTEPARIN SODIUM, PER 2500 IU ADMINISTERED


subject: UMLS:C0498888


subject: UMLS:C0498888


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: cholangiocarcinoma of the gallbladder


subject: UNII:68AYS9A614

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: UNII:68AYS9A614

object_name: Recurrent Cancer of Gallbladder


subject: UNII:68AYS9A614

object_name: Malignant neoplasm of gallbladder recurrent


subject: UNII:68AYS9A614

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: UNII:68AYS9A614

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: UNII:68AYS9A614

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:68AYS9A614

object_name: cholangiocarcinoma


subject: UNII:68AYS9A614

object_name: periampullary adenocarcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UNII:6Z3QHB00LB

subject_name: Bimiralisib

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3489662

object_name: diabetic macular edema


subject: UMLS:C3489662

object_name: age-related macular degeneration


subject: UMLS:C1567931

subject_name: Macugen

object_name: X-linked reticulate pigmentary disorder


subject: UNII:3HP012Q0FH


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:2735

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:2735

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:41423

object_name: stage IA breast cancer


subject: CHEBI:41423

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:41423

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681

object_name: Carcinoma breast stage IV


subject: CHEBI:25681


subject: CHEBI:25681

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: CHEBI:231324

subject_name: alpelisib

object_name: melanoma


subject: CHEBI:231324

object_name: skin melanoma


subject: UMLS:C5557579

subject_name: AsiDNA

object_name: Recurrent ovarian cancer


subject: UMLS:C5557579

object_name: Childhood Breast Carcinoma


subject: UMLS:C5557579

object_name: breast carcinoma


subject: UMLS:C5557579

object_name: breast cancer


subject: UMLS:C5557579

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:6067

object_name: childhood myelodysplastic syndrome


subject: CHEBI:6067

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:6067

object_name: acute myeloid leukemia


subject: CHEBI:32139

object_name: Disorder of transplanted kidney


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Coronavinae infectious disease


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:31348

subject_name: Capecitabine

object_name: prostate carcinoma


subject: CHEBI:31348

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven


subject: PUBCHEM.COMPOUND:3844471


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Vascular Stiffness


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801

object_name: Complications of Diabetes Mellitus


subject: CHEMBL.COMPOUND:CHEMBL4802185

subject_name: MAPLIRPACEPT

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4725956

subject_name: SIRPa-IgG4 Fc


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: HIV infection


subject: CHEBI:90841

subject_name: Cangrelor

object_name: Cardiorespiratory arrest with successful resuscitation


subject: UMLS:C5706297

subject_name: B-GOS

object_name: pervasive developmental disorder


subject: UMLS:C5706297

object_name: autism


subject: UMLS:C0795649

subject_name: oat bran

object_name: arteriosclerosis disorder


subject: UMLS:C0795649

object_name: atherosclerosis


subject: UMLS:C0795649

object_name: Hypercholesterolemia


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: UMLS:C4086994


subject: UMLS:C3256348

subject_name: Carica papaya leaf extract

object_name: thrombocytopenia


subject: CHEBI:50459

object_name: Intrabony periodontal defect


subject: CHEBI:50459

object_name: Periodontal Pocket


subject: CHEBI:50459

object_name: periodontitis


subject: CHEBI:50459

object_name: periodontal disorder


subject: CHEBI:9635

subject_name: Toremifene

object_name: Breast Pain, CTCAE 5.0


subject: CHEBI:9635

object_name: Mastalgia


subject: CHEBI:9635

object_name: BREAST PAIN FEMALE


subject: CHEBI:9635

object_name: Breast Pain, CTCAE 3.0


subject: CHEBI:9434

subject_name: Telmisartan

object_name: diabetic kidney disease


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: chronic urticaria


subject: UMLS:C0910794


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Patent ductus arteriosus after premature birth


subject: UNII:H5212R2DPM

object_name: pancreatic ductal adenocarcinoma


subject: DRUGBANK:DB19210


subject: CHEBI:60775

subject_name: Verteporfin

object_name: glioblastoma


subject: CHEBI:60775

object_name: Childhood Glioblastoma


subject: CHEBI:60775

object_name: adult glioblastoma


subject: CHEBI:60775

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:60775

object_name: Recurrent Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: castration-resistant prostate carcinoma


subject: UNII:91X1KLU43E


subject: UNII:91X1KLU43E

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:91X1KLU43E

object_name: prostate adenocarcinoma


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:U59UGK3IPC

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2934225


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib


subject: UNII:38073MQB2A


subject: PUBCHEM.COMPOUND:11756905

subject_name: Delamanid

object_name: TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: pancreatic neoplasm


subject: UNII:3934EF02T7

object_name: exocrine pancreatic carcinoma


subject: UNII:3934EF02T7

object_name: malignant pancreatic neoplasm


subject: UNII:3934EF02T7

object_name: Childhood Breast Carcinoma


subject: UNII:3934EF02T7

object_name: breast carcinoma


subject: UNII:3934EF02T7

object_name: breast cancer


subject: UMLS:C1721684

subject_name: lexatumumab

object_name: prostate carcinoma


subject: UMLS:C1721684

object_name: prostate cancer


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: EXCESS LMW-DNA


subject: CHEBI:28680

subject_name: Cytarabine


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Premenopausal breast cancer


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: neuroendocrine neoplasm


subject: CHEBI:64220

subject_name: monosodium glutamate


subject: CHEBI:16015

subject_name: Glutamic acid


subject: UMLS:C0037511

subject_name: sodium glutamate


subject: UMLS:C5854426

subject_name: Anti-B7-H4/Anti-4-1BB Bispecific Antibody CLN-418

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:32551

object_name: Prediabetes


subject: CHEBI:29967

subject_name: L-lysine residue


subject: CHEBI:133538

subject_name: Lysine


subject: UMLS:C0024337

subject_name: lysine


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: HIV infection


subject: CHEBI:6950

object_name: Harmful pattern of substance use


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: infiltrating bladder urothelial carcinoma


subject: UNII:DPT0O3T46P

object_name: Bladder transitional cell carcinoma stage II


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: Cholangiocarcinoma non-resectable


subject: UNII:MF4P7VQ2K8

subject_name: TAVOKINOGENE TELSEPLASMID

object_name: mycosis fungoides


subject: UMLS:C5700412

subject_name: Tavo


subject: UMLS:C3896874

object_name: ovarian cancer


subject: UMLS:C3896874

object_name: ovarian neoplasm


subject: UMLS:C3896874

object_name: ovarian carcinoma


subject: CHEBI:37845

subject_name: growth hormone

object_name: Female infertility due to diminished ovarian reserve


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: UMLS:C0699617

subject_name: Norditropin


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Peptic Ulcer


subject: CHEBI:37941

subject_name: Clopidogrel


subject: GTOPDB:8932

subject_name: pepinemab

object_name: Osteosarcoma recurrent


subject: GTOPDB:8932

object_name: Refractory Osteosarcoma


subject: GTOPDB:8932

object_name: Refractory Malignant Solid Neoplasm


subject: GTOPDB:8932

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:BPZ4A29SYE

subject_name: PEPINEMAB


subject: UNII:BPZ4A29SYE


subject: UNII:BPZ4A29SYE


subject: UNII:BPZ4A29SYE


subject: UMLS:C3272653


subject: UMLS:C3272653


subject: UMLS:C3272653


subject: UMLS:C3272653


subject: UMLS:C0556083

subject_name: Essential amino acid supplementation

object_name: Fragility fracture


subject: UMLS:C0556083

object_name: Femur fracture


subject: UMLS:C0556083

object_name: Muscle Atrophy


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Encounter Admission Source - labor and delivery


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:62166

subject_name: Rebastinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: nonpapillary renal cell carcinoma


subject: UNII:3934EF02T7

object_name: clear cell renal carcinoma


subject: UNII:3934EF02T7

object_name: renal cell adenocarcinoma


subject: UNII:3934EF02T7

object_name: renal cell carcinoma


subject: UNII:3934EF02T7

object_name: renal carcinoma


subject: UNII:3934EF02T7

object_name: kidney neoplasm


subject: UNII:3934EF02T7

object_name: kidney cancer


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Ependymoma


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Brain Stem Glioma


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Pineoblastoma


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Medulloblastoma


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UNII:01KC87F8FE

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: UNII:01KC87F8FE

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: UNII:01KC87F8FE

object_name: childhood central nervous system germ cell tumor


subject: UNII:01KC87F8FE

object_name: childhood choroid plexus neoplasm


subject: UNII:01KC87F8FE

object_name: pediatric infratentorial ependymoma


subject: UNII:01KC87F8FE

object_name: Childhood Grade I Meningioma


subject: UNII:01KC87F8FE

object_name: pediatric supratentorial ependymoma


subject: UNII:01KC87F8FE

object_name: childhood high-grade cerebellar astrocytoma


subject: UNII:01KC87F8FE

object_name: childhood low-grade cerebellar astrocytoma


subject: UNII:01KC87F8FE

object_name: childhood low-grade cerebral astrocytoma


subject: UNII:01KC87F8FE

object_name: Childhood Grade III Meningioma


subject: UNII:01KC87F8FE

object_name: Childhood Grade II Meningioma


subject: UNII:01KC87F8FE

object_name: childhood medulloepithelioma


subject: UNII:01KC87F8FE

object_name: Childhood Craniopharyngioma


subject: UNII:01KC87F8FE

object_name: pediatric cerebral ependymoblastoma


subject: UNII:01KC87F8FE

object_name: Childhood Mixed Glioma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Recurrent Childhood Brain Stem Glioma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Pineoblastoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: UNII:PVI5M0M1GW

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: UNII:PVI5M0M1GW

object_name: childhood central nervous system germ cell tumor


subject: UNII:PVI5M0M1GW

object_name: pediatric infratentorial ependymoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Grade I Meningioma


subject: UNII:PVI5M0M1GW

object_name: pediatric supratentorial ependymoma


subject: UNII:PVI5M0M1GW

object_name: childhood high-grade cerebellar astrocytoma


subject: UNII:PVI5M0M1GW

object_name: childhood low-grade cerebellar astrocytoma


subject: UNII:PVI5M0M1GW

object_name: childhood low-grade cerebral astrocytoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Grade III Meningioma


subject: UNII:PVI5M0M1GW

object_name: Childhood Grade II Meningioma


subject: UNII:PVI5M0M1GW

object_name: childhood medulloepithelioma


subject: UNII:PVI5M0M1GW

object_name: Childhood Craniopharyngioma


subject: UNII:PVI5M0M1GW

object_name: childhood oligodendroglioma


subject: UNII:PVI5M0M1GW

object_name: pediatric cerebral ependymoblastoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Mixed Glioma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: Recurrent Childhood Brain Stem Glioma


subject: PR:000005932

object_name: Recurrent Childhood Pineoblastoma


subject: PR:000005932

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: PR:000005932

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: PR:000005932

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: PR:000005932

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: PR:000005932

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: PR:000005932

object_name: childhood central nervous system germ cell tumor


subject: PR:000005932

object_name: pediatric infratentorial ependymoma


subject: PR:000005932

object_name: Childhood Grade I Meningioma


subject: PR:000005932

object_name: pediatric supratentorial ependymoma


subject: PR:000005932

object_name: childhood high-grade cerebellar astrocytoma


subject: PR:000005932

object_name: childhood low-grade cerebellar astrocytoma


subject: PR:000005932

object_name: childhood low-grade cerebral astrocytoma


subject: PR:000005932

object_name: Childhood Grade III Meningioma


subject: PR:000005932

object_name: Childhood Grade II Meningioma


subject: PR:000005932

object_name: childhood medulloepithelioma


subject: PR:000005932

object_name: Childhood Craniopharyngioma


subject: PR:000005932

object_name: childhood oligodendroglioma


subject: PR:000005932

object_name: pediatric cerebral ependymoblastoma


subject: PR:000005932

object_name: Childhood Mixed Glioma


subject: CHEBI:3534

subject_name: Cephalexin

object_name: Recurrent urinary tract infections


subject: CHEBI:8382

subject_name: Prednisone

object_name: Inflammation


subject: CHEBI:93775

subject_name: Amethopterin

object_name: vasculitis


subject: CHEBI:93775

object_name: Vasculitis, CTCAE


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:139072

object_name: Severe depression


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:30687

subject_name: osmium atom

object_name: Post-Operative Pain


subject: CHEBI:8499

subject_name: Propranolol

object_name: Hypoxemia


subject: CHEBI:8499

object_name: Hypoxia, CTCAE


subject: UMLS:C0873173

subject_name: red yeast rice extract

object_name: hyperlipidemia


subject: UMLS:C0873173

object_name: hyperlipoproteinemia


subject: UMLS:C0873173

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C0873173

object_name: Serum lipids high (finding)


subject: UMLS:C0873173

object_name: coronary artery disorder


subject: UMLS:C0873173

object_name: coronary atherosclerosis


subject: MESH:C117343

subject_name: red yeast rice


subject: MESH:C117343


subject: MESH:C117343


subject: MESH:C117343


subject: MESH:C117343


subject: CHEMBL.COMPOUND:CHEMBL1201451

subject_name: ALBUMIN HUMAN

object_name: Community-Acquired Pneumonia


subject: CHEMBL.COMPOUND:CHEMBL1201451

object_name: Hypoalbuminemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1201451

object_name: Serum albumin level decreased below normal (finding)


subject: CHEMBL.COMPOUND:CHEMBL1201451

object_name: Hypoalbuminemia


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4

object_name: renal carcinoma


subject: UMLS:C3495434

object_name: kidney neoplasm


subject: UMLS:C3495434

object_name: kidney cancer


subject: CHEBI:9434

subject_name: Telmisartan

object_name: peripheral vascular disease


subject: CHEBI:9434

object_name: peripheral arterial disease


subject: CHEBI:50841

subject_name: Loxapine

object_name: neuralgia


subject: CHEBI:50841

object_name: Neuropathic pain


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: hepatitis E


subject: CHEBI:85083

object_name: Chronic viral hepatitis


subject: CHEBI:15765

subject_name: Levodopa

object_name: schizotypal personality disorder


subject: CHEBI:64187

subject_name: Benserazide


subject: UMLS:C3529783

object_name: Nerve Pain


subject: UMLS:C3529783


subject: UMLS:C3529783


subject: UMLS:C3529783

object_name: Nociceptive Pain


subject: CHEBI:28241

subject_name: Papaverine

object_name: induced; birth


subject: CHEBI:230956

object_name: Childhood Breast Carcinoma


subject: CHEBI:230956

object_name: breast carcinoma


subject: CHEBI:230956

object_name: breast cancer


subject: CHEBI:45307

subject_name: Seliciclib


subject: CHEBI:45307


subject: CHEBI:45307


subject: UNII:85KUE857XM

subject_name: SHR-1258 dimaleate

object_name: HER2 mutant non-small cell lung cancer


subject: UMLS:C5206643

subject_name: Pyrotinib Dimaleate


subject: UNII:612K359T69

subject_name: ALVESPIMYCIN HYDROCHLORIDE

object_name: prolymphocytic leukemia


subject: UNII:612K359T69

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:612K359T69

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C2698077

subject_name: Alvespimycin Hydrochloride


subject: UMLS:C2698077


subject: UMLS:C2698077


subject: UMLS:C2729286

subject_name: Injection, docetaxel, 1 mg administered

object_name: prostate carcinoma


subject: UMLS:C2729286

object_name: prostate cancer


subject: UMLS:C5203163

subject_name: Docetaxel Liquid Injection


subject: UMLS:C5203163


subject: UMLS:C5847502

subject_name: Agave Inulin

object_name: Pediatric Obesity


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: CHEBI:125427

object_name: secondary hyperparathyroidism


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UMLS:C1703576

subject_name: immune globulin subcutaneous (human)

object_name: inborn error of immunity


subject: CHEBI:27732

subject_name: Caffeine

object_name: Postoperative Complications


subject: CHEBI:42588

subject_name: Fenretinide


subject: CHEBI:42588


subject: CHEBI:42588


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: tuberculosis


subject: CHEBI:10110

subject_name: Zidovudine


subject: UMLS:C3692257

subject_name: Basic Fibroblast Growth Factor

object_name: periodontitis


subject: UMLS:C0380603

subject_name: Fibroblast Growth Factor 2


subject: CHEBI:145431

subject_name: Indisulam

object_name: leukemia


subject: CHEBI:145431

object_name: childhood leukemia


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: Solid Neoplasm


subject: CHEBI:9168

subject_name: Sirolimus

object_name: coronary restenosis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adult germ cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: germ cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: childhood germ cell tumor


subject: UNII:2S9ZZM9Q9V

object_name: Germ Cell Cancer


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Evidence of liver transplantation


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C4301616

subject_name: fluoroestradiol (18F)

object_name: breast lobular carcinoma


subject: UMLS:C5439626

subject_name: Fluoroestradiol f 18, diagnostic, 1 millicurie


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Nonulcer dyspepsia


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: PUBCHEM.COMPOUND:51059404

subject_name: Blisibimod

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:51059404

object_name: autoimmune thrombocytopenia


subject: UNII:114VP6C6ES

subject_name: BLISIBIMOD


subject: UNII:114VP6C6ES


subject: UMLS:C3713826


subject: UMLS:C3713826


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Headache


subject: CHEBI:135207

object_name: Headache, CTCAE


subject: CHEBI:135207

object_name: Tension-type headache


subject: CHEBI:135207

object_name: Episodic tension-type headache


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Arterial Stiffness


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Neuroblastoma recurrent


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Arthritis, CTCAE


subject: CHEBI:46195

object_name: myocardial infarction


subject: CHEBI:46195

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:46195

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: arthritis


subject: CHEBI:5855


subject: CHEMBL.COMPOUND:CHEMBL1201451

subject_name: ALBUMIN HUMAN

object_name: Burn injury


subject: CHEBI:95165

object_name: Advanced breast cancer


subject: CHEBI:50131

subject_name: Decitabine


subject: UMLS:C4722192

subject_name: Interleukin-7 human recombinant

object_name: HIV infection


subject: CHEBI:37845

subject_name: growth hormone

object_name: adrenal; functional disturbance


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: UMLS:C3554917

subject_name: Abilify Maintena

object_name: schizophrenia


subject: UMLS:C3554917

object_name: Isomerism of left atrial appendage


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:48843

subject_name: sodium selenite

object_name: prostate adenocarcinoma


subject: CHEBI:48843

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:48843

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:48843

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:48843

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:48843

object_name: Prostate cancer recurrent


subject: CHEBI:48843

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:48843

object_name: plasma cell myeloma


subject: CHEBI:48843

object_name: plasmacytoma


subject: CHEBI:91083

subject_name: Romiplostim

object_name: Ewing sarcoma


subject: UMLS:C1505595


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Local recurrence of malignant tumor of breast


subject: CHEBI:17439

subject_name: Cyanocobalamin

object_name: hand-foot syndrome


subject: CHEBI:17439

object_name: Sickle Cell Dactylitis


subject: UNII:F3HG38I0T1

subject_name: IMVOTAMAB

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:F3HG38I0T1

object_name: non-Hodgkin lymphoma


subject: UNII:F3HG38I0T1

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:F3HG38I0T1

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:F3HG38I0T1

object_name: mantle cell lymphoma


subject: UNII:F3HG38I0T1

object_name: follicular lymphoma


subject: UNII:F3HG38I0T1

object_name: marginal zone lymphoma


subject: UNII:F3HG38I0T1

object_name: MALT lymphoma


subject: UNII:F3HG38I0T1

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5236954

subject_name: Imvotamab


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: UMLS:C5236954


subject: GTOPDB:7385

subject_name: catumaxomab

object_name: Malignant ascites


subject: UNII:M2HPV837HO


subject: UMLS:C1831854


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: Functional capacity


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:6121

subject_name: Ketamine

object_name: Delayed Emergence from Anesthesia


subject: CHEBI:32599


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: ovarian cancer


subject: CHEBI:82677

object_name: ovarian neoplasm


subject: CHEBI:82677

object_name: ovarian carcinoma


subject: UMLS:C0796524

subject_name: Monoclonal Antibody F19

object_name: colorectal cancer


subject: UMLS:C0796524

object_name: colorectal carcinoma


subject: UMLS:C0796524

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4744969

subject_name: Micro Needle Array-Doxorubicin

object_name: skin squamous cell carcinoma


subject: UMLS:C4744969

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4744969

object_name: Skin cancers - squamous cell carcinoma


subject: CHEBI:16899

subject_name: Mannitol

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:16899

object_name: reactive airway disease


subject: CHEBI:16899

object_name: obstructive lung disease


subject: CHEBI:16899

object_name: Allergy


subject: CHEBI:16899

object_name: History of allergies


subject: UMLS:C5203185

subject_name: Amikacin Sulfate Injection

object_name: Neonatal Late-Onset Sepsis


subject: UMLS:C0812788

subject_name: INJECTION, AMIKACIN SULFATE, 100 MG Administered


subject: CHEBI:228488

subject_name: Stiripentol

object_name: Hyperoxaluria


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: vaginal discharge


subject: UMLS:C0812735

object_name: Vaginal Discharge, CTCAE


subject: UMLS:C0812735

object_name: Vaginal Discharge


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:140628

subject_name: Secnidazole


subject: CHEBI:140628


subject: CHEBI:140628


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Bleeding gastric varices


subject: MESH:D006495

object_name: Anticoagulants and Bleeding Disorders


subject: MESH:D006495

object_name: Tissue Adhesion


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: CAPN5-related vitreoretinopathy


subject: CHEBI:9667

object_name: proliferative vitreoretinopathy


subject: CHEBI:9667

object_name: retinal detachment


subject: CHEBI:9667

object_name: Retinal Detachment, CTCAE 3.0


subject: CHEBI:9667

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:9667

object_name: retinoschisis


subject: DRUGBANK:DB10651

subject_name: Rhubarb

object_name: diabetic kidney disease


subject: GTOPDB:10236

subject_name: volociximab

object_name: Metastatic Cutaneous Melanoma


subject: GTOPDB:10236

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: GTOPDB:10236

object_name: metastatic melanoma


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UNII:IA262432Y9

object_name: mild neurocognitive disorder


subject: UNII:IA262432Y9

object_name: mild cognitive impairment


subject: UMLS:C1505675


subject: UMLS:C1505675


subject: UMLS:C4724855

subject_name: BCD 100

object_name: melanoma


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: peripheral nervous system disorder


subject: UNII:M487QF2F4V

object_name: neuropathy


subject: UNII:M487QF2F4V

object_name: gestational trophoblastic neoplasm


subject: UMLS:C1706792

subject_name: Amifostine Trihydrate


subject: UMLS:C1706792


subject: UMLS:C1706792


subject: UMLS:C1706792

object_name: neurotoxicity


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: PUBCHEM.COMPOUND:22573923

subject_name: Ipamorelin

object_name: ileus


subject: PUBCHEM.COMPOUND:22573923

object_name: Ileus, CTCAE


subject: UMLS:C0757797

subject_name: ipamorelin


subject: UMLS:C0757797


subject: DRUGBANK:DB15844

subject_name: CVnCoV

object_name: multiple sclerosis


subject: MESH:C000722934

subject_name: CVnCoV COVID-19 vaccine


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: Delirium in old age


subject: CHEBI:2677

subject_name: Augmentin

object_name: Penile prosthesis infection


subject: CHEBI:2677

object_name: impotence


subject: CHEBI:2677

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:2677

object_name: Erectile dysfunction


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: RXCUI:151392


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:9332


subject: RXCUI:151399

subject_name: Bactrim


subject: RXCUI:151399


subject: RXCUI:151399


subject: RXCUI:151399


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648


subject: CHEBI:60648


subject: CHEBI:60648


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: invasive aspergillosis


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C2987384

subject_name: BMN 673

object_name: Myelodysplasia


subject: UMLS:C2987384

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C2987384

object_name: childhood myelodysplastic syndrome


subject: UMLS:C2987384

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2987384

object_name: mantle cell lymphoma


subject: UMLS:C2987384

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2987384

object_name: acute myeloid leukemia


subject: UMLS:C2987384

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: UNII:6897GXD6OE

object_name: COPD, severe early onset


subject: UMLS:C0086477

subject_name: Berofor

object_name: melanoma


subject: UMLS:C0728761

subject_name: Velban


subject: CHEBI:3756

subject_name: Clonazepam

object_name: glossodynia


subject: UMLS:C5667044

subject_name: Botanical-based Agent NBT-NM108

object_name: multiple sclerosis


subject: UMLS:C4733080

subject_name: liposome-encapsulated irinotecan hydrochloride PEP02

object_name: colorectal cancer


subject: UMLS:C4733080

object_name: colorectal carcinoma


subject: UMLS:C4733080

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:149504

object_name: Prediabetes


subject: CHEBI:149504

object_name: glucose intolerance


subject: CHEBI:149504

object_name: Impaired glucose tolerance


subject: CHEBI:149504

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:149504

object_name: Obesity, CTCAE


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: cervical cancer


subject: UMLS:C0935868

object_name: cervical carcinoma


subject: UMLS:C0059079

subject_name: EMLA

object_name: Primary malignant neoplasm


subject: UMLS:C0059079

object_name: cancer


subject: UMLS:C0059079

object_name: childhood malignant neoplasm


subject: UMLS:C0059079

object_name: Malignant obstetric neoplasm


subject: UMLS:C5706364

subject_name: Anti-BAFFR Monoclonal Antibody ESG206

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:10033

subject_name: Warfarin

object_name: Gastrointestinal hemorrhage


subject: CHEBI:134267

subject_name: 3,5-diiodothyropropionic acid

object_name: Allan-Herndon-Dudley syndrome


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: type 1 diabetes mellitus 1


subject: CHEBI:3654

object_name: type 1 diabetes mellitus


subject: CHEBI:3654

object_name: Hypercalciuria


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: Gene mutations and other alterations NEC


subject: CHEBI:50634

object_name: Mountain Sickness


subject: CHEBI:50634

object_name: polycythemia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939

object_name: acute mountain sickness


subject: CHEBI:28939


subject: UMLS:C4745029

subject_name: HLX 10

object_name: Microsatellite instability-high solid malignant tumor


subject: MESH:C539075

subject_name: opalustre

object_name: dental fluorosis


subject: MESH:C539075

object_name: Enamel discoloration


subject: UNII:4YK5Z54AT2

subject_name: [OBSOLETE] denatonium benzoate

object_name: Heartburn


subject: CHEBI:232400

subject_name: denatonium benzoate


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Microsatellite instability-high colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4541385

subject_name: Heplisav-B

object_name: chronic kidney disease


subject: UMLS:C4541385

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4289046

subject_name: Gallium Ga 68-NOTA-BBN(7-14)-RGD

object_name: prostate carcinoma


subject: UMLS:C4289046

object_name: prostate cancer


subject: CHEBI:7726

subject_name: octreotide

object_name: Hypothalamic obesity


subject: CHEBI:49140

object_name: pulmonary fibrosis


subject: CHEBI:49140

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: UNII:TUK9QB44B0


subject: UNII:TUK9QB44B0


subject: UMLS:C5392518


subject: UMLS:C5392518


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Ischemic stroke


subject: UNII:2BT4C47RUI

subject_name: Necitumumab

object_name: Solid Neoplasm


subject: CHEBI:91951

object_name: BRCA1 gene mutation


subject: CHEBI:91951

object_name: BRCA2 gene mutation


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: UNII:W2P7EF7O6O

object_name: Prosthetic joint infection


subject: DRUGBANK:DB16312


subject: UMLS:C0753357

subject_name: MultiHance

object_name: peripheral vascular disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Chagas cardiomyopathy


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Activating EGFR Gene Mutation


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C0260264

subject_name: steroid drugs

object_name: Post-Operative Pain


subject: UMLS:C0306166

subject_name: Factrel

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:7TK323DLA0

subject_name: NOGAPENDEKIN ALFA INBAKICEPT

object_name: Metastatic urothelial carcinoma


subject: UNII:7TK323DLA0

object_name: urothelial carcinoma


subject: UNII:7TK323DLA0

object_name: transitional cell carcinoma


subject: UNII:7TK323DLA0

object_name: Locally Advanced Urothelial Carcinoma


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3542463

subject_name: tbo-filgrastim

object_name: leukopenia


subject: UMLS:C3542463

object_name: neutropenia


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: leukemia


subject: CHEBI:2676

object_name: childhood leukemia


subject: CHEBI:2676

object_name: plasma cell myeloma


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: UMLS:C0041044


subject: UMLS:C1567966

subject_name: Triptans

object_name: headache disorder


subject: UNII:760I9WM792

subject_name: Lasmiditan

object_name: migraine with aura


subject: UNII:760I9WM792


subject: UMLS:C4704729

subject_name: GEPANTS

object_name: migraine


subject: UMLS:C4704729

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C4704729


subject: UMLS:C4704729


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:135436482

object_name: lymphoma


subject: PUBCHEM.COMPOUND:135436482

object_name: pediatric lymphoma


subject: UMLS:C3713905

object_name: kidney failure


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: genetic disease


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:9168

subject_name: Sirolimus

object_name: immunodeficiency disease


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: acromegaly


subject: PUBCHEM.COMPOUND:73151030

object_name: Acral overgrowth


subject: PUBCHEM.COMPOUND:73151030

object_name: cardiomyopathy


subject: CHEBI:170007

subject_name: Nirmatrelvir

object_name: long COVID-19


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Refractory angina


subject: UMLS:C3539110

subject_name: house dust mites (allergen extract)

object_name: allergic asthma


subject: UNII:P7186074QC

subject_name: Rozanolixizumab

object_name: thrombocytopenia


subject: UMLS:C5226617


subject: CHEBI:15365

subject_name: Aspirin

object_name: typhoid fever


subject: DRUGBANK:DB11050

subject_name: Typhoid Vaccine Live

object_name: Inflammation


subject: UMLS:C5227010

object_name: multiple system atrophy


subject: UMLS:C0019731

subject_name: HLA-A1 Antigen

object_name: lung cancer


subject: UMLS:C0019731

object_name: lung neoplasm


subject: UMLS:C0019731

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:5281767

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:5281767

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:5281767

object_name: Depression, CTCAE


subject: CHEBI:24859

subject_name: iodine atom

object_name: Selenium deficiency


subject: CHEBI:24859

object_name: autoimmune thyroid disease


subject: CHEBI:17606

subject_name: Iodine


subject: CHEBI:17606


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: UMLS:C0885449


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: Iodine deficiency


subject: HMDB:HMDB0001349


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C3831604

subject_name: Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine

object_name: colon carcinoma


subject: UMLS:C3831604

object_name: colorectal cancer


subject: UMLS:C3831604

object_name: colon cancer


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: nonpapillary renal cell carcinoma


subject: UNII:2Y3T5IF01Z

object_name: renal cell adenocarcinoma


subject: UNII:2Y3T5IF01Z

object_name: renal cell carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919

object_name: clear cell renal carcinoma


subject: CHEBI:66919


subject: CHEBI:66919


subject: PUBCHEM.COMPOUND:134129840

subject_name: POLYMYXIN B

object_name: Healthcare associated pneumonia


subject: PUBCHEM.COMPOUND:134129840

object_name: bacteriemia


subject: PUBCHEM.COMPOUND:134129840

object_name: Bacteremia, CTCAE


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B


subject: PUBCHEM.COMPOUND:4868


subject: PUBCHEM.COMPOUND:4868


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEBI:135928

subject_name: Doripenem


subject: CHEBI:135928


subject: CHEBI:135928


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: Adult Anaplastic (Malignant) Meningioma


subject: CHEBI:5864

object_name: adult meningeal hemangiopericytoma


subject: CHEBI:5864

object_name: bone chondrosarcoma


subject: CHEBI:5864

object_name: chondrosarcoma


subject: CHEBI:139072

object_name: Chronic Post-Traumatic Stress Disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: UMLS:C3641662

object_name: liver carcinoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: alcohol withdrawal


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:5103

subject_name: Flumazenil

object_name: gastric neoplasm


subject: PR:000015975

subject_name: sperm motility kinase Tcr mutant form

object_name: metastatic melanoma


subject: PR:000015975

object_name: Disseminated Malignant Neoplasm


subject: PR:000015975

object_name: Embolism, Tumor


subject: PR:000015975

object_name: Neoplasm Metastasis


subject: UMLS:C0034790

subject_name: T-Cell Receptor


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: UMLS:C0034790


subject: PR:000001318

subject_name: L-selectin


subject: PR:000001318


subject: PR:000001318


subject: PR:000001318


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin

object_name: Immunosuppression


subject: PUBCHEM.COMPOUND:72995949

object_name: Decreased Immunologic Activity [PE]


subject: PUBCHEM.COMPOUND:3685

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:3685

object_name: chronic myelomonocytic leukemia


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor


subject: UMLS:C0376562


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Celiac disease in children


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UNII:913P6LK81M

subject_name: Doravirine

object_name: latent tuberculosis infection


subject: UNII:913P6LK81M

object_name: Medication interaction potentiation


subject: UNII:913P6LK81M

object_name: Adverse effects in the therapeutic use of rifamycins


subject: CHEBI:135117

subject_name: ftivazide


subject: CHEBI:135117


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: HMDB:HMDB0015332

subject_name: Rifapentine


subject: HMDB:HMDB0015332


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Cough


subject: CHEBI:50275

object_name: Cough, CTCAE


subject: UMLS:C3896913

subject_name: CYP17 Lyase Inhibitor ASN001

object_name: prostate carcinoma


subject: UMLS:C3896913

object_name: prostate cancer


subject: UMLS:C3896913

object_name: prostate neoplasm


subject: UniProtKB:P36632

subject_name: RAD26_SCHPO DNA repair protein rad26 (sprot)

object_name: HIV infection


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: Partial Seizure


subject: MESH:D010919

subject_name: Placebos

object_name: glucose intolerance


subject: MESH:D010919

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:73701

subject_name: Val-Pro


subject: UMLS:C5202958

subject_name: V-Series Nerve Agent VP


subject: PR:000004523

subject_name: vasopressin-neurophysin 2-copeptin


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Neck Carcinoma


subject: UNII:GKF8S4C432

object_name: Recurrent disease


subject: UNII:GKF8S4C432

object_name: Distantly Metastatic Malignant Neoplasm


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:70839

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Relapse multiple myeloma


subject: CHEBI:70839

object_name: Acute lymphocytic leukaemia refractory


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:71157

subject_name: Dobesilic acid

object_name: agranulocytosis


subject: CHEBI:71157

object_name: Agranulocytosis


subject: CHEBI:71157

object_name: Endometrial bleeding


subject: CHEBI:71157

object_name: Hemorrhage


subject: CHEBI:71157

object_name: Uterine hemorrhage


subject: CHEBI:71157

object_name: hypersensitivity response


subject: UMLS:C0877940

subject_name: Doxium


subject: UMLS:C0877940


subject: UMLS:C0877940


subject: UMLS:C0877940


subject: UMLS:C0877940


subject: UMLS:C0877940


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518


subject: CHEBI:94518


subject: CHEBI:125400

subject_name: actinomycin D

object_name: Metastatic Ewing's Sarcoma


subject: KEGG.COMPOUND:C01775

subject_name: Actinomycin


subject: CHEBI:27666

subject_name: Dactinomycin


subject: UMLS:C0001259


subject: UMLS:C3536807

subject_name: Actinomycin [EPC]


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:63632

subject_name: Topotecan


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: HER2-positive gastric cancer


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage III Vulvar Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Vulval cancer stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Vulvar Cancer AJCC v6


subject: PUBCHEM.COMPOUND:2767

object_name: Vulval cancer metastatic


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Vulvar Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IVB Vulvar Cancer AJCC v8


subject: GTOPDB:12966

subject_name: cadonilimab


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Delayed Emergence from Anesthesia


subject: CHEBI:231324

subject_name: alpelisib

object_name: acute myeloid leukemia


subject: UMLS:C2986399


subject: UMLS:C2830125


subject: CHEBI:145371

subject_name: Binimetinib


subject: UMLS:C4305940

object_name: AIDS


subject: UMLS:C4305940

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma


subject: CHEBI:229212

object_name: Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: plasma cell myeloma


subject: CHEBI:95060

object_name: Solid Neoplasm


subject: CHEBI:95060

object_name: B-CELL MALIGNANCY, LOW-GRADE


subject: CHEBI:95060

object_name: leukemia, chronic lymphocytic, susceptibility to, 2


subject: CHEBI:95060

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:95060

object_name: non-Hodgkin lymphoma


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: UMLS:C2711996


subject: CHEBI:65326

subject_name: Pictilisib


subject: CHEBI:50178

subject_name: chloroquine sulfate

object_name: Coronavinae infectious disease


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Leukokeratosis


subject: CHEBI:8214

subject_name: Pindolol

object_name: endogenous depression


subject: CHEBI:8214

object_name: major depressive disorder


subject: CHEBI:228346

object_name: narcolepsy


subject: CHEBI:39112

subject_name: Bosutinib

object_name: pancreatic neoplasm


subject: CHEBI:39112

object_name: exocrine pancreatic carcinoma


subject: CHEBI:39112

object_name: malignant pancreatic neoplasm


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: viral encephalitis


subject: CHEBI:234112

subject_name: Cenobamate

object_name: generalized epilepsy


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: metastatic prostate carcinoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: leukemia


subject: UNII:C137DTR5RG

object_name: childhood leukemia


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: UNII:11Z5AIU653

subject_name: simtuzumab

object_name: myelofibrosis


subject: CHEMBL.COMPOUND:CHEMBL2109667

subject_name: SIMTUZUMAB


subject: UMLS:C2984523


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: Solid Neoplasm


subject: GTOPDB:13880


subject: UMLS:C5706402

subject_name: EGFR/HER2 Inhibitor ORIC-114


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: PUBCHEM.COMPOUND:58008990

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: PUBCHEM.COMPOUND:58008990

object_name: Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C1321600

subject_name: Silver nitrate stain

object_name: Anterior epistaxis


subject: CHEBI:32130

subject_name: Silver nitrate


subject: UMLS:C1161347

subject_name: Argentum nitricum, silver nitrate


subject: UMLS:C0718099

subject_name: trichloroacetic acid topical


subject: PUBCHEM.COMPOUND:49785800

subject_name: SULOPENEM ETZADROXIL

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:49785800

object_name: Recurrent urinary tract infections


subject: PUBCHEM.COMPOUND:49785800

object_name: cystitis


subject: PUBCHEM.COMPOUND:49785800

object_name: Cystitis, CTCAE


subject: CHEBI:8426

subject_name: Probenecid


subject: CHEBI:8426


subject: CHEBI:8426


subject: CHEBI:8426


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: endogenous depression


subject: UNII:91X1KLU43E

object_name: major depressive disorder


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Demonstrates adequate pain control


subject: UMLS:C4733033

subject_name: Nasalfent


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:95341

subject_name: Baricitinib

object_name: graft versus host disease


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: otitis externa


subject: CHEBI:41879

object_name: Otitis Externa, CTCAE


subject: UniProtKB:C1P607

subject_name: IBSA_ECOLI Small toxic protein IbsA (sprot)

object_name: infertility


subject: PR:000022983

subject_name: small toxic protein IbsA


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:63791

object_name: primary cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:135565596

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: thyroid gland papillary carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: thyroid cancer, nonmedullary, 2


subject: PUBCHEM.COMPOUND:135565596

object_name: Thyroid cancer (follicular cell)


subject: PUBCHEM.COMPOUND:135565596

object_name: BRAF V600E mutation positive


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: CHEBI:63637


subject: UMLS:C4318848

subject_name: Pain Relieving

object_name: Low back pain


subject: RXCUI:1747691

subject_name: emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet

object_name: HIV infection


subject: RXCUI:1747691

object_name: Substance Use Disorders


subject: UNII:DFK2GHG34Y

object_name: Adult Solid Neoplasm


subject: UMLS:C5785762

subject_name: Anti-LILRB Monoclonal Antibody ADA-011


subject: CHEBI:33363

subject_name: palladium


subject: CHEBI:74756

subject_name: Pro-Asp


subject: CHEBI:45951

subject_name: Trifluoperazine

object_name: pure red-cell aplasia


subject: CHEBI:45951

object_name: Diamond-Blackfan anemia


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: Cicatrization


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:229221

object_name: RENAL CELL CARCINOMA, CLEAR CELL, SOMATIC


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Neonatal infection


subject: UMLS:C3540708

object_name: Neonatal disorder caused by noxious substance transmitted via breast milk


subject: UMLS:C3540708

object_name: Prenatal Exposure Delayed Effects


subject: UMLS:C3540708

object_name: Dysbiosis


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Hypoxemia


subject: PUBCHEM.COMPOUND:9824461

object_name: Hypoxia, CTCAE


subject: PUBCHEM.COMPOUND:9824461

object_name: Overweight or obesity


subject: PUBCHEM.COMPOUND:2269

object_name: anemia


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Irritable heart


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:149504